| Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 E Whittaker, A Bamford, J Kenny, M Kaforou, CE Jones, P Shah, ... Jama 324 (3), 259-269, 2020 | 2094 | 2020 |
| Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature GI Rice, PR Kasher, GMA Forte, NM Mannion, SM Greenwood, ... Nature genetics 44 (11), 1243-1248, 2012 | 841 | 2012 |
| Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response GI Rice, J Bond, A Asipu, RL Brunette, IW Manfield, IM Carr, JC Fuller, ... Nature genetics 41 (7), 829-832, 2009 | 782 | 2009 |
| Paediatric tuberculosis SM Newton, AJ Brent, S Anderson, E Whittaker, B Kampmann The Lancet infectious diseases 8 (8), 498-510, 2008 | 759 | 2008 |
| Kawasaki-like disease: emerging complication during the COVID-19 pandemic RM Viner, E Whittaker The Lancet 395 (10239), 1741-1743, 2020 | 560 | 2020 |
| Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study P Davies, C Evans, HK Kanthimathinathan, J Lillie, J Brierley, G Waters, ... The Lancet Child & Adolescent Health 4 (9), 669-677, 2020 | 547 | 2020 |
| A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process R Harwood, B Allin, CE Jones, E Whittaker, P Ramnarayan, AV Ramanan, ... The Lancet Child & Adolescent Health 5 (2), 133-141, 2021 | 366 | 2021 |
| PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with … E Whittaker, A Bamford, J Kenny, M Kaforou, CE Jones, P Shah, ... JAMA 324 (3), 259-269, 2020 | 361 | 2020 |
| Treatment of multisystem inflammatory syndrome in children AJ McArdle, O Vito, H Patel, EG Seaby, P Shah, C Wilson, C Broderick, ... New England Journal of Medicine 385 (1), 11-22, 2021 | 346 | 2021 |
| Community transmission of monkeypox in the United Kingdom, April to May 2022 R Vivancos, C Anderson, P Blomquist, S Balasegaram, A Bell, L Bishop, ... Eurosurveillance 27 (22), 2200422, 2022 | 337 | 2022 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study IM Osmanov, E Spiridonova, P Bobkova, A Gamirova, A Shikhaleva, ... European Respiratory Journal 59 (2), 2022 | 311 | 2022 |
| Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test B Kampmann, E Whittaker, A Williams, S Walters, A Gordon, ... European Respiratory Journal 33 (6), 1374-1382, 2009 | 243 | 2009 |
| Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents RM Viner, JL Ward, LD Hudson, M Ashe, SV Patel, D Hargreaves, ... Archives of disease in childhood 106 (8), 802-807, 2021 | 242 | 2021 |
| Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study T Stephenson, SMP Pereira, R Shafran, BL De Stavola, N Rojas, ... The Lancet Child & Adolescent Health 6 (4), 230-239, 2022 | 200 | 2022 |
| 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective … J Penner, O Abdel-Mannan, K Grant, S Maillard, F Kucera, J Hassell, ... The Lancet Child & Adolescent Health 5 (7), 473-482, 2021 | 181 | 2021 |
| Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNγ? E Whittaker, A Gordon, B Kampmann PloS one 3 (12), e3901, 2008 | 161 | 2008 |
| Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year C Smith, D Odd, R Harwood, J Ward, M Linney, M Clark, D Hargreaves, ... Nature medicine 28 (1), 185-192, 2022 | 131 | 2022 |
| Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020 J Flood, J Shingleton, E Bennett, B Walker, Z Amin-Chowdhury, G Oligbu, ... The Lancet Regional Health–Europe 3, 2021 | 117 | 2021 |
| Tuberculosis susceptibility and protection in children RB Roy, E Whittaker, JA Seddon, B Kampmann The Lancet Infectious Diseases 19 (3), e96-e108, 2019 | 114 | 2019 |
Christine E JonesUniversity of SouthamptonDirección de correo verificada de soton.ac.uk
